QNCX
Quince Therapeutics, Inc.
30.20$
-3.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +844.3% | +70.7% | +52.3% | -29.7% | -22.0% | +73.4% | -36.5% | -18.3% | |
| – | +863.0% | +46.1% | +30.0% | -19.0% | -16.1% | -17.4% | -43.1% | -48.0% | |
| – | +238.7% | +105.9% | +30.5% | +4.3% | -36.1% | -53.4% | -70.1% | -6.5% | |
| – | +876.7% | +39.2% | +34.0% | -20.2% | -15.6% | -16.8% | -45.7% | -56.5% | |
| – | – | – | – | – | -11.1% | -1.0% | -11.2% | +310.7% | |
| – | – | – | – | – | +1.8% | – | – | – | |
| – | – | +371.4% | -17.5% | +29.7% | -72.5% | – | – | – | |
| – | – | – | – | – | – | – | -100.0% | – | |
| – | – | – | – | – | – | +979.2% | -5.7% | +12.9% | |
| – | -94.8% | +510.3% | +93.5% | -14.9% | -77.3% | +2,767.7% | -11.3% | +53.2% | |
| – | -17.4% | +510.3% | +91.1% | -16.3% | -78.4% | +211.9% | -24.0% | +493.9% | |
| – | – | – | – | +211.3% | -38.9% | -85.9% | +50.0% | +18,796.9% | |
| – | -4.3% | +521.2% | +15.6% | +38.1% | -88.4% | +256.7% | +42.8% | -23.4% | |
| – | – | – | – | – | – | – | +6.6% | – | |
| – | – | +61.7% | +49.2% | -31.2% | -15.2% | -15.4% | -64.6% | -218.5% | |
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -11.7% | +53.3% | +1.9% | +12.7% | +11.2% | +16.2% | +15.8% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.